Clinical

Dataset Information

Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer


ABSTRACT: The investigators propose to assess the efficacy, progression-free survival, and adverse events of pacritinib in patients with refractory colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2177220 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR